Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 510 | 152 | 970 | 356 | 483 |
| Cost of Goods | 1 | 302 | 286 | 5 | 19 |
| Gross Profit | 509 | -150 | 683 | 351 | 464 |
| Operating Expenses | 5,215 | 6,919 | 16,084 | 12,062 | 8,989 |
| Operating Income | -4,705 | -6,767 | -15,114 | -11,706 | -8,506 |
| Interest Expense | 826 | 1,314 | 294 | 227 | 405 |
| Other Income | 162 | 56 | -106 | 722 | -1,903 |
| Pre-tax Income | -5,370 | -8,025 | -15,515 | -11,211 | -10,814 |
| Income Tax | -111 | 256 | 798 | 825 | -220 |
| Net Income Continuous | -5,259 | -8,281 | -16,312 | -12,036 | -10,594 |
| Minority Interests | -356 | -493 | 111 | 803 | -802 |
| Net Income | $-4,903 | $-7,788 | $-16,423 | $-12,839 | $-9,791 |
| EPS Basic Total Ops | -0.42 | -1.80 | -5.19 | -5.10 | -5.00 |
| EPS Basic Continuous Ops | -0.45 | -1.91 | -5.15 | -4.80 | -5.37 |
| EPS Diluted Total Ops | -0.42 | -1.80 | -5.19 | -5.10 | -5.00 |
| EPS Diluted Continuous Ops | -0.45 | -1.91 | -5.15 | -4.80 | -5.37 |
| EPS Diluted Before Non-Recurring Items | -0.42 | -2.43 | -5.20 | -5.10 | N/A |
| EBITDA(a) | $-4,504 | $-6,386 | $-15,091 | $-11,694 | $-8,469 |